BeiGene Ltd (BGNE) reported a Q3 net loss Tuesday of $1.15 per American depositary share, swinging from earnings of $2.01 a year earlier.
Analysts polled by Capital IQ expected a loss of $0.99.
Revenue for the quarter ended Sept. 30 was $1 billion, up from $781.3 million a year earlier.
Analysts surveyed by Capital IQ expected $984.2 million.
Price: 222.99, Change: -4.06, Percent Change: -1.79
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。